Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GBA1 | P04062 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30274154 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL19861525 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL4958591 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL3722250 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL5074939 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9LGALS1 | |
| Hydrochloric Acid SCHEMBL29164309 | 0.98 | CA12 (0.36) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL27659442 | 0.87 | CA12 (0.32) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL18769795 | 0.87 | CA12 (0.32) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL31006210 | 0.80 | LGALS1 (0.34) | CA12CA1CA2CA9LGALS1 | |
| SCHEMBL25432185 | 0.78 | LGALS1 (0.39) | CA12CA1CA2CA9LGALS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2700717-B1 | Method for the diagnosis of lysosomal storage diseases | PRZYBYLSKI MICHAEL (DE) | 2016-06-01 | — | — | EP | claimed |
| EP-2700717-A1 | Method for the diagnosis of lysosomal storage diseases | Universität Konstanz (DE) | 2014-02-26 | — | — | EP | claimed |
| JP-2025494-A | — | — | None | — | — | JP | disclosed |
| US-20250275993-A1 | GLYCOSYLATION INHIBITORS AS THERAPEUTICS FOR STROKE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-04 | — | — | US | disclosed |
| CN-120076831-A | Anti-ROR 1 antibodies and antibody conjugates, compositions comprising anti-ROR 1 antibodies or antibody conjugates, and methods of making and using anti-ROR 1 antibodies and antibody conjugates | 苏特罗生物制药公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119455004-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119455003-A | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-113660957-B | Compositions, methods and uses comprising antibody-TLR agonist conjugates | AMBRX公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-110637027-B | Modified relaxin polypeptides comprising pharmacokinetic enhancers and uses thereof | 百时美施贵宝公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118459618-A | Novel galactosylated glycosaminoglycan and preparation method and application thereof | 中国科学院昆明植物研究所 | 2024-08-09 | — | — | CN | disclosed |
| CN-117924503-A | Humanized anti-Prostate Specific Membrane Antigen (PSMA) antibody drug conjugates | AMBRX公司 | 2024-04-26 | — | — | CN | disclosed |
| US-8846620-B2 | Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides | BAXTER INTERNATIONAL INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140271608-A1 | RESORPTION ENHANCERS AS ADDITIVES TO IMPROVE THE ORAL FORMULATION OF LOW MOLECULAR WEIGHT HEPARINS | BAXTER HEALTHCARE S.A. (CH) | 2014-09-18 | — | — | US | disclosed |
| EP-2700717-A1 | Method for the diagnosis of lysosomal storage diseases | Universität Konstanz (DE) | 2014-02-26 | — | — | EP | disclosed |
| US-20130035288-A1 | Resorption Enhancers As Additives To Improve The Oral Formulation Of Non-Anticoagulant Sulfated Polysaccharides | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-07 | — | — | US | disclosed |
| WO-2010118516-A1 | COMPOSITIONS FOR SUBLINGUAL DRUG DELIVERY AND METHODS OF USE THEREOF | GLOBE LABORATORIES INC. (CA) | 2010-10-21 | — | — | WO | disclosed |
| EP-1455817-B1 | STAPHYLOCOCCUS AUREUS EXOPOLYSACCHARIDE AND PROCESS | MERCK & CO INC (US) | 2008-12-31 | — | — | EP | disclosed |
| EP-1455817-A4 | STAPHYLOCOCCUS AUREUS EXOPOLYSACCHARIDE AND PROCESS | MERCK & CO INC (US) | 2005-11-30 | — | — | EP | disclosed |
| EP-1455817-A2 | STAPHYLOCOCCUS AUREUS EXOPOLYSACCHARIDE AND PROCESS | Merck & Co., Inc. (US) | 2004-09-15 | — | — | EP | disclosed |
| JP-H0225494-A | GLUCOSAMINE DERIVATIVE | HASEGAWA AKIRA | 1990-01-26 | — | — | JP | disclosed |